Zentalis Pharmaceuticals, Inc. (ZNTL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
10275 Science Center Drive
San Diego, CA 92121
United States of America (the)
Phone
212 433 3791
Website
Sector
Healthcare
Industry
Biotechnology
Employees
106
First IPO Date
April 03, 2020
| Name | Title | Pay | Year Born |
| Julie Eastland | Chief Executive Officer, President & Director | 1.14M | 1964 |
| James Bucher | Chief Legal Officer & Corporate Secretary | 556,683 | 1966 |
| Ingmar Bruns | Chief Medical Officer | 825,952 | 1975 |
| Henry Gu | Senior Vice President & Head of Intellectual Property | 0 | N/A |
| Rajesh Israni | Executive VP of Regulatory Affairs & Medical Writing | 0 | N/A |
| Robert J. DiVasto | Chief Technical Officer | 0 | 1956 |
| Vincent Vultaggio | SVP of Finance & Principal Accounting Officer | 0 | 1984 |
| Sarah Kelly | Senior Vice President of Commercial Strategy | 0 | N/A |
| Haibo Wang | Chief Business Officer | 0 | N/A |
| Wendy Chang | Chief People Officer | 0 | N/A |
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.